Back

Clinical trial evidence in heart failure with reduced ejection fraction

10 May 2026 (09:48 - 10:00)
Organised by: Logo
Congress Presentation Part of: Innovative approaches in the management of patients with heart failure with reduced ejection fraction (HFrEF) in the era of guideline-directed medical therapy (GDMT) Heart Failure with Reduced Ejection Fraction (HFrEF) Open Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor William Abraham

The Ohio State University, Columbus (United States of America)

5 More presentations in this session

Presentation thumbnail
Welcome and Introduction: unmet needs in the era of guideline-directed medical therapy
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
Latest analyses in HFrEF, diagnosis, patient selection, and clinical experience
Doctor J. Nunez Villota (Valencia, ES)
Slides Video
Presentation thumbnail
Panel discussion
Video
Presentation thumbnail
Cardiac device management in heart failure: myths and misconceptions
Doctor S. Zieroth (Winnipeg, CA)
Slides Video
Presentation thumbnail
Panel discussion
Video

Access the full session

Session thumbnail
Innovative approaches in the management of patients with heart failure with reduced ejection fraction (HFrEF) in the era of guideline-directed medical therapy (GDMT)
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 09:48 CET
You may be interested in
thumbnail
Congress Session
Interatrial shunts therapy for heart failure: the road ahead
thumbnail
Congress Presentation
Ongoing trials and future prospectives
thumbnail
Congress Session
Interatrial shunt devices: a new tool for heart failure treatment?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources